Long-term outcomes of hemostatic therapy for variceal bleeding and the challenge pending in the post-direct-acting antivirals era.

K Shibata, K Yokoyama, R Yamauchi, K Matsumoto, S Himeno, T Nagata, T Higashi, T Kitaguchi, H Fukuda, N Tsuchiya, A Fukunaga, K Takata, T Tanaka, Y Takeyama, S Shakado, S Sakisaka, F Hirai

Acta gastro-enterologica Belgica 2022 Jan-Mar

filter terms:

This study evaluated the longterm outcomes of mainly endoscopic hemostatic therapy for gastrointestinal variceal bleeding and of the transition of hemostatic therapy. Among 1,163 patients treated for gastrointestinal varices between April 2006 and June 2020, a total of 125 patients who underwent emergency hemostatic therapy were enrolled. Survival rates and secondary evaluation points were analyzed. Additionally, patients were classified into two groups: the previous and latter term. Patients' background, therapeutic method, and treatment results were compared between the groups. 94.4% had cirrhosis. The average Child-Pugh score was 8.90. Successful primary hemostasis rate was 98.4%, and 5.6% died within 2 weeks, all with a Child-Pugh score ≥9. The respective 1- and 5-year survival rates for Child-Pugh grade A/B were 81.3% and 55.4%, while those for Child-Pugh grade C were 58.1% and 17.8%. Child-Pugh grade C or hepatocellular carcinoma was significantly associated with poor prognosis. In total, 21.6% experienced variceal re-bleeding; 62.9% of these cases were triggered by continued alcohol consumption. There was no significant difference in survival between patients with and without variceal re-bleeding and in post-treatment survival between the previous and latter terms. In the latter term, the number of cases caused by continued alcohol consumption significantly increased. Multidisciplinary treatment and continuation of proper management after hemostatic therapy for variceal bleeding are crucial. Continued alcohol consumption leads to variceal bleeding and re-bleeding; its proper management, including alcohol abstinence, is one of the major challenges left in the post-directacting antivirals era. © Acta Gastro-Enterologica Belgica.

Citation

K Shibata, K Yokoyama, R Yamauchi, K Matsumoto, S Himeno, T Nagata, T Higashi, T Kitaguchi, H Fukuda, N Tsuchiya, A Fukunaga, K Takata, T Tanaka, Y Takeyama, S Shakado, S Sakisaka, F Hirai. Long-term outcomes of hemostatic therapy for variceal bleeding and the challenge pending in the post-direct-acting antivirals era. Acta gastro-enterologica Belgica. 2022 Jan-Mar;85(1):7-14